Clinical Trial Update: Study Assessing Effects of JZP-110 on Driving Performance in the Treatment of Excessive Sleepiness in Narcolepsy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effects of JZP-110 on driving performance in adults with narcolepsy and excessive daytime sleepiness has completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Excessive Daytime Sleepiness
• Narcolepsy

Drugs mentioned

• JZP-110

Snippet

Sponsor: Jazz Pharmaceuticals | Conditions: Narcolepsy, Excessive Sleepiness | Phase 2 | Status: COMPLETED | Results posted: 2021-01-13